Vanguard Group Inc Immix Biopharma, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMMX
# of Institutions
36Shares Held
5.09MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.56MShares$3.05 Million1.92% of portfolio
-
Bleichroeder LP New York, NY850KShares$1.67 Million0.81% of portfolio
-
Cable Car Capital LLC San Francisco, CA670KShares$1.31 Million2.84% of portfolio
-
Lynwood Capital Management Inc.405KShares$793,80011.13% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny266KShares$520,3800.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $27.3M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...